Xenon Pharmaceuticals
XENE
#2963
Rank
HK$40.72 B
Marketcap
HK$426.73
Share price
-1.89%
Change (1 day)
59.25%
Change (1 year)

Market capitalization of Xenon Pharmaceuticals (XENE)

Market cap: HK$40.72 Billion

As of March 2026 Xenon Pharmaceuticals has a market cap of HK$40.72 Billion. This makes Xenon Pharmaceuticals the world's 2963th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Xenon Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$40.72 B51.04%
2025HK$26.96 B17.3%
2024HK$22.98 B-15.13%
2023HK$27.07 B40.54%
2022HK$19.26 B53.33%
2021HK$12.56 B201.04%
2020HK$4.17 B45.3%
2019HK$2.87 B125.8%
2018HK$1.27 B220.3%
2017HK$0.39 B-62.82%
2016HK$1.06 B19.18%
2015HK$0.89 B-58.74%
2014HK$2.17 B

End of Day market cap according to different sources

On Mar 27th, 2026 the market cap of Xenon Pharmaceuticals was reported to be:

HK$35.49 Billion
by Nasdaq info icon info icon
HK$40.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Coherus BioSciences
CHRS
HK$1.91 B-95.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
HK$0.29 B-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA